Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms TM-04-168-03 |
Mechanism PIP4K2A inhibitors(phosphatidylinositol-5-phosphate 4-kinase type 2 alpha inhibitors), PIP4K2B inhibitors(phosphatidylinositol-5-phosphate 4-kinase type 2 beta inhibitors), PIP4K2C inhibitors(phosphatidylinositol-5-phosphate 4-kinase type 2 gamma inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest Phase- |
First Approval Date- |
Regulation- |
Molecular FormulaC43H35N9O8 |
InChIKeyHOISUMPGDHVJQI-UHFFFAOYSA-N |
CAS Registry- |